The clinical utility of blood-based biomarkers of Alzheimer's disease: Triumphs and pitfalls.
This chapter examines the clinical utility of key blood-based biomarkers, including phosphorylated tau, amyloid-β ratios, neurofilament light chain, and glial fibrillary acidic protein, within the context of current diagnostic frameworks.